Supplier
Cipla Europe NV
Antwerpen · BEL
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Awards
24
Total awarded
—
6 joint award(s) counted pro rata
Buyers
3
Sectors
1
Group: Cipla Europe NV
Reg. 0539.790.548
Contracts this supplier holds that are running out
14 Apr 2027
estimatedAbschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Rivaroxaban, ATC B01AF01 für die Zeit 01.04.2026 - 30.06.2026—DAK-Gesundheit089PHARM GmbH, 1 A Pharma GmbH, AAA Pharma GmbH +13 more
- —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
31 Mar 2028
stated - —
30 Jun 2028
stated - —
30 Jun 2028
stated 30 Jun 2028
statedTenofovir disoproxil—GWQ ServicePlus AGBG Heumann / Heunet GbR, Cipla Europe NV, PUREN Pharma GmbH & Co. KG